 Addition of the decahydroisoquinoline (DIQ) group was one of the most significant modifications that led to the discovery of saquinavir.This substituent improves aqueous solubility and potency by limiting the conformational freedom of the inhibitor.Saquinavir is effective against both HIV-1 and HIV-2 and is usually well tolerated but high serum concentration is not achieved.